Drug-drug interaction through molecular structure similarity analysis
By Santiago Vilar, R. Harpaz, E. Uriarte, L. Santana, Raul Rabadan, Carol Friedman. 2012
260 citations recorded by the source corpus.
Subfields: Computational Theory and Mathematics, Molecular Biology, Toxicology
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Computational Theory and Mathematics
- Marinka Zitnik
- Fei Wang
- Jure Leskovec
- Stephen H. Bryant
- Anna Goldenberg
- Jiayu Zhou
- Olivier Elemento
- Sang Yup Lee
In Molecular Biology
- Marinka Zitnik
- Fei Wang
- Jure Leskovec
- Anna Goldenberg
- Stephen H. Bryant
- Michael M. Hoffman
- Francis Nguyen
- Yanli Wang
In Toxicology
Citations in the corpus
- Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties. (2014, unknown): “Equation 3 has been corrected.”
- Machine Learning for Integrating Data in Biology and Medicine: Principles, Practice, and Opportunities (2018, background): “In contrast, similarity-based approaches assume that similar drugs have similar interaction patterns [298, 299, 289, 254, 33, 291, 300].”
- Label Propagation Prediction of Drug-Drug Interactions Based on Clinical Side Effects (2015, methodology): “Similarity-based approach is a representative strategy for DDI prediction 10,12,15 .”
- Deep learning improves prediction of drug–drug and drug–food interactions (2018, background): “This inference was based on a well-known assumption that a drug pair A is likely to have the same DDI as another drug pair B if both drug pairs have structurally similar drug members (8).”
- Towards Personalized Medicine: Leveraging Patient Similarity and Drug Similarity Analytics (2014, background): “Drug similarity analytics has been widely used in drug repositioning 7-9 , drug side-effects prediction 10 , drug-target interactions prediction 11 , and drug-drug interactions prediction 12, 13 applications.”
- Graph convolutional networks for computational drug development and discovery (2019, methodology): “Traditional computational methods aggregate drug and target features or similarity measures to identify interactions using standard machine learning algorithms [59–62].”
- Predicting drug–drug interactions through drug structural similarities and interaction networks incorporating pharmacokinetics and pharmacodynamics knowledge (2017, methodology): “Structural similarity for DDI prediction has been employed based on the idea that if there is a DDI between drug A and drug B, and drug C has a similar structure to drug A, there is likely a DDI between drug C and drug B [8].”